These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 20263122)

  • 1. Experimental field-type suppression with SN 7618 (chloroquine) SN 8137 and SN 12,837 (paludrine).
    PACKER H
    J Natl Malar Soc; 1947 Jun; 6(2):147-54. PubMed ID: 20263122
    [No Abstract]   [Full Text] [Related]  

  • 2. Toxicity of antimalarial drugs; therapeutic doses of chloroquine, paludrine, and pentaquine.
    FERBER CJ; CHINN HI
    Q Res Rep; 1948 Jan 1-Mar 31; 60():28. PubMed ID: 18912261
    [No Abstract]   [Full Text] [Related]  

  • 3. The estimation of paludrine in urine.
    GAGE JC; ROSE FL
    Ann Trop Med Parasitol; 1946 Dec; 40(3-4):333-6. PubMed ID: 20289234
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical trials of paludrine.
    QASIR A; PRINGLE G; AMIN ZAKI L
    J R Fac Med Iraq; 1947; 11(3):73-7. PubMed ID: 20257867
    [No Abstract]   [Full Text] [Related]  

  • 5. Activation of paludrine in vitro.
    HAWKING F
    Nature; 1947 Mar; 159(4038):409. PubMed ID: 20291789
    [No Abstract]   [Full Text] [Related]  

  • 6. Distribution of paludrine in whole blood and plasma.
    TOTTEY M; ANDREWS WH; MAEGRAITH B
    Trans R Soc Trop Med Hyg; 1947 Mar; 40(4):367. PubMed ID: 20290655
    [No Abstract]   [Full Text] [Related]  

  • 7. The inhibition of esterases by paludrine.
    Blaschko H; Chou TC; Wajda I
    Br J Pharmacol Chemother; 1947 Jun; 2(2):116-20. PubMed ID: 19108109
    [No Abstract]   [Full Text] [Related]  

  • 8. The absorption and excretion of paludrine in the human subject.
    MAEGRAITH BG; TOTTEY MM
    Ann Trop Med Parasitol; 1946 Dec; 40(3-4):493-506. PubMed ID: 20289245
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of the action of paludrine (proguanil), chloroquine and camoquin in single doses.
    CHAUDHURI RN; RAI CHAUDHURI MN; GOSH S; DUTTA BN
    Indian J Malariol; 1950 Jun; 4(2):135-49. PubMed ID: 24540997
    [No Abstract]   [Full Text] [Related]  

  • 10. Modern antimalarial therapy.
    PFEIFFER CC
    Mod Hosp; 1952 Aug; 79(2):106-8. PubMed ID: 12992919
    [No Abstract]   [Full Text] [Related]  

  • 11. [Paludrine (proguanil, chlorguanide) in clinical prophylaxis].
    van GOOR WT; LODENS JG
    Med Maandbl; 1950 Mar; 3(3):103-21. PubMed ID: 24537268
    [No Abstract]   [Full Text] [Related]  

  • 12. Malaria treated successfully with resochin.
    DUTTA KK
    Antiseptic; 1952 May; 49(5):392-4. PubMed ID: 14934093
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapy of malaria with nivaquine B].
    CARRESCIA M
    Riv Malariol; 1952 Dec; 31(4-6):157-61. PubMed ID: 13028095
    [No Abstract]   [Full Text] [Related]  

  • 14. [Compound baskir].
    Rev Kuba Med Trop Parasitol; 1951; 7(11-12):156-60. PubMed ID: 14921070
    [No Abstract]   [Full Text] [Related]  

  • 15. [Therapy of malaria; standardization of resochin therapy].
    LOZANO MORALES A
    Rev Sanid Hig Publica (Madr); 1952; 26(7-8):426-8. PubMed ID: 13004516
    [No Abstract]   [Full Text] [Related]  

  • 16. [Value of resochin therapy of primary chronic rheumatism].
    KAZIOR A
    Pol Tyg Lek; 1959 Aug; 14():1456-8. PubMed ID: 14405046
    [No Abstract]   [Full Text] [Related]  

  • 17. [Plasmodium berghei in mice; appearance of a state of immunity following repeated treatments with nivaquine during relapse].
    LAPIERRE J
    Bull Soc Pathol Exot Filiales; 1954; 47(3):380-7. PubMed ID: 13219588
    [No Abstract]   [Full Text] [Related]  

  • 18. [Duhring-Brocq disease treated by combined aureomycin-nivaquine and maintained by nivaquine alone].
    COLOMB D; CAJGFINGER H
    Lyon Med; 1956 Jun; 88(25):547-8. PubMed ID: 13347214
    [No Abstract]   [Full Text] [Related]  

  • 19. [Three cases of Dühring-Brocq disease successfully treated by a combination of aureomycin and nivaquine].
    GATE J; COLOMB D; CAJGFINGER H
    Bull Soc Fr Dermatol Syphiligr; 1956; (2):176-7. PubMed ID: 13342802
    [No Abstract]   [Full Text] [Related]  

  • 20. [Three new cases of Duhring-Brocq disease having benefited from combined aureomycin-nivaquine therapy].
    GATE J; COLOMB D; CAJGFINGER H
    Lyon Med; 1956 Jun; 88(24):527-9. PubMed ID: 13347212
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.